4/A

OWNERSHIP DOCUMENT

Company: ADMA BIOLOGICS, INC.
Filed: November 16, 2017
Period of Report: November 9, 2017
Accession Number: 0001193805-17-003506

View Document ↗ View on SEC.gov ↗